OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15

Showing 15 citing articles:

Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9

Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies
Bahaa G. M. Youssif, Martha M. Morcoss, Stefan Bräse, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 446-446
Open Access | Times Cited: 6

Grinding-assisted synthesis of novel arylhydrazono curcumin analogues and bis-pyrazolines as cyclin-dependent kinases (CDKs) inhibitors
Sobhi M. Gomha, Sayed M. Riyadh, Abdel‐Aziz A. A. El‐Sayed, et al.
Inorganic Chemistry Communications (2024) Vol. 169, pp. 113128-113128
Closed Access | Times Cited: 3

Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8

Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Hesham A. Abou‐Zied, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136953-136953
Closed Access | Times Cited: 5

Novel benzothiazole–pyrazoline–styrene hybrid for ultrasensitive detection of Hg(II) ions: Synthesis and chemosensor evaluation
Devi Ratnawati, Indriana Kartini, Harno Dwi Pranowo, et al.
Luminescence (2024) Vol. 39, Iss. 6
Closed Access | Times Cited: 1

Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 1

Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1

Recent Advances: Heterocycles in Drugs and Drug Discovery
Ivana Pibiri
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9503-9503
Open Access | Times Cited: 1

Emerging insights into pyrazoline motifs: A comprehensive exploration of biological mechanisms and prospects for future advancements
Hesham A. Abou‐Zied, Eman A. M. Beshr, Alaa M. Hayallah, et al.
Journal of Molecular Structure (2023) Vol. 1296, pp. 136807-136807
Closed Access | Times Cited: 4

Targeted Development of Pyrazoline Derivatives for Neurological Disorders: A Review
Anurag Chauhan, Salahuddin Salahuddin, Avijit Mazumder, et al.
ChemistrySelect (2024) Vol. 9, Iss. 16
Closed Access

Synthesis, Anticancer Activity, and Computational Studies of New Pyrazole Derivatives
A.-E. Khairulah, Zainab Al Shuhaib, Raed A. Alharis, et al.
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 3, pp. 719-728
Closed Access

Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access

New Pyrazole/Pyrimidine-Based Scaffolds as Inhibitors of Heat Shock Protein 90 Endowed with Apoptotic Anti-Breast Cancer Activity
Lamya H. Al-Wahaibi, Mohammed A. I. Elbastawesy, Nader E. Abo‐Dya, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1284-1284
Open Access

Design, synthesis, and antiproliferative activity of new 1,2,3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
RSC Advances (2024) Vol. 14, Iss. 52, pp. 38403-38415
Open Access

Page 1

Scroll to top